Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-Month and 1-year follow-up assessment - A virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial

JACC: Cardiovascular Interventions

Volumn 5, Issue 6, 2012, Pages 656-665

  Gogas, Bill D ^a   Serruys, Patrick W ^a   Diletti, Roberto ^a   Farooq, Vasim ^a   Brugaletta, Salvatore ^a   Radu, Maria D ^a   Heo, Jung Ho ^a   Onuma, Yoshinobu ^a   Van Geuns, Robert Jan M ^a   Regar, Evelyn ^a   De Bruyne, Bernard ^b   Chevalier, Bernard ^c   Thuesen, Leif ^d   Smits, Pieter C ^e   Dudek, Dariusz ^f   Koolen, Jacques ^g   Windecker, Stefan ^h   Whitbourn, Robert ⁱ   Miquel Hebert, Karine ^j   Dorange, Cecile ^j   Rapoza, Richard ^j   Garcia Garcia, Hector M ^k   McClean, Dougal ^l   Ormiston, John A ^m   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

^c Institut Jacques Cartier   (France)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e Maasstad Hospital ^*  (Netherlands)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g CATHARINA HOSPITAL   (Netherlands)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j ABBOTT VASCULAR   (United States)

^k CARDIALYSIS   (Netherlands)

^l CHRISTCHURCH HOSPITAL   (New Zealand)

^m AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

ABSORB bioresorbable vascular scaffold; edge vascular response; virtual histology intravascular ultrasound assessment

Indexed keywords

BIORESORBABLE VASCULAR SCAFFOLD; CALCIUM; EVEROLIMUS; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR CALCIFICATION;

EID: 84862904152     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.02.017     Document Type: Article

References (27)

1. Costa MA, Angiolillo DJ, Tannenbaum M, et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 2008;101:1704-11.
2. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42. (Pubitemid 36070930)
3. Serruys PW, Degertekin M, Tanabe K, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004;109: 627-33. (Pubitemid 38198870)
4. García-García HM, Gonzalo N, Tanimoto S, Meliga E, de Jaegere P, Serruys PW. Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) study. Rev Esp Cardiol 2008;61:1013-9.
5. Chieffo A, Foglieni C, Nodari RL, et al. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009;104:1660-7.
6. Byrne RA, Eberle S, Kastrati A, et al. Distribution of angiographic measures of restenosis after drug-eluting stent implantation. Heart 2009;95:1572-8.
7. Onuma Y, Serruys PW, Perkins LE, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 2010;122:2288-300.
8. Gogas BD, Radu M, Onuma Y, et al. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies. Int J Cardiovasc Imaging 2012;28:499-516.
9. Gogas BD, Farooq V, Serruys PW, et al. Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond. Int J Cardiovasc Imaging 2011;27:225-37.
10. Hoffmann R, Guagliumi G, Musumeci G, et al. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized e-Sirius, and Sirius trials. Catheter Cardiovasc Interv 2005;66:499-506. (Pubitemid 41779015)
11. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108:1701-6. (Pubitemid 37243657)
12. Wentzel JJ, Gijsen FJ, Stergiopulos N, Serruys PW, Slager CJ, Krams R. Shear stress, vascular remodeling and neointimal formation. J Biomech 2003;36:681-8. (Pubitemid 36407620)
13. Wentzel JJ, Whelan DM, van der Giessen WJ, et al. Coronary stent implantation changes 3-d vessel geometry and 3-d shear stress distribution. J Biomech 2000;33:1287-95. (Pubitemid 30427325)
14. Thury A, Wentzel JJ, Vinke RV, et al. Images in cardiovascular medicine. Focal in-stent restenosis near step-up: roles of low and oscillating shear stress? Circulation 2002;105:e185-7.
15. Gomez-Lara J, Garcia-Garcia HM, Onuma Y, et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. J Am Coll Cardiol Intv 2010;3:1190-8.
16. Tortoriello A, Pedrizzetti G. Flow-tissue interaction with compliance mismatch in a model stented artery. J Biomech 2004;37:1-11. (Pubitemid 37532624)
17. Samady H, Eshtehardi P, McDaniel MC, et al. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation 2011;124:779-88.
18. Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004;110:940-7. (Pubitemid 39128619)
19. Kim SW, Mintz GS, Hong YJ, et al. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 2008;102:1182-6.
20. Bruining N, de Winter S, Roelandt JR, et al. Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. J Am Coll Cardiol Intv 2010;3:449-56.
21. Arbab-Zadeh A, DeMaria AN, Penny WF, Russo RJ, Kimura BJ, Bhargava V. Axial movement of the intravascular ultrasound probe during the cardiac cycle: implications for three-dimensional reconstruction and measurements of coronary dimensions. Am Heart J 1999;138: 865-72. (Pubitemid 29523273)
22. von Birgelen C, de Vrey EA, Mintz GS, et al. ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 1997;96:2944-52. (Pubitemid 27500094)
23. Bruining N, von Birgelen C, de Feyter PJ, et al. ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. Cathet Cardiovasc Diagn 1998; 43:254-60.
24. Verheye S, Martinet W, Kockx MM, et al. Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol 2007;49:706-15. (Pubitemid 46205042)
25. Hong MK, Park DW, Lee CW, et al. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. J Am Coll Cardiol Intv 2009;2:679-88.
26. Lavi S, Bae JH, Rihal CS, et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart 2009;95:1525-30.
27. Brugaletta S, Heo HJ, Garcia-Garcia HM, et al. Endothelial-dependent vasomotion in coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J 2012 Apr 16 [E-pub ahead of print].